受注:045-509-1970 |
技術サポート:[email protected] 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
製品コード:A2816 Batch: A281602
Visilizumab (Anti-CD3) is a humanized, non-Fc receptor (FcR)-binding IgG2 monoclonal antibody (MoAb) directed against CD3 with potential immunosuppressive activity. Visilizumab has the potential to be used for ulcerative colitis and Crohn's disease research. MW : 144.62 KD.
CAS No. | 219716-33-3 |
---|---|
Formulation | 100mMPro-Ac,20mMArg-Ac,pH5.0 |
Isotype | Human IgG2SA |
Source | CHO |
Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
Shipping | Shipped under low temperature conditions |
Purity | 99% |
Protein concentration | 8.23mg/ml |
Endotoxin Level | <1EU/mg |
人間や獣医の診断であるか治療的な使用のためにでない。